JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.09B |
| 2 |
Broadcom
AVGO
|
+$1.03B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$970M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$877M |
| 5 |
Verizon
VZ
|
+$875M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.37B |
| 3 |
TWX
Time Warner Inc
TWX
|
+$764M |
| 4 |
IBM
IBM
|
+$737M |
| 5 |
Philip Morris
PM
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Financials | 14% |
| 3 | Technology | 12.71% |
| 4 | Healthcare | 9.7% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3401
Coca-Cola Consolidated
COKE
$12.5B
| $1.59M | ﹤0.01% |
117,910
+48,160
| +69% | +$710K |
2016 Q4
6 quarters
|
|
|
CATM
3402
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $1.59M | ﹤0.01% |
65,907
-328,115
| -83% | -$8.5M |
2013 Q2
20 quarters
|
|
3403
CALL
ING
ING
$97.5B
| $1.59M | ﹤0.01% |
111,000
| – | – |
2018 Q1
1 quarter
|
|
3404
iShares Core 10+ Year USD Bond ETF
ILTB
$588M
| $1.59M | ﹤0.01% |
26,500
-1,788
| -6% | -$108K |
2014 Q3
15 quarters
|
|
3405
Mercantile Bank Corp
MBWM
$1.02B
| $1.59M | ﹤0.01% |
43,019
+11,675
| +37% | +$419K |
2016 Q2
8 quarters
|
|
3406
Arbutus Biopharma
ABUS
$903M
| $1.59M | ﹤0.01% |
217,501
-4,828
| -2% | -$28.7K |
2016 Q4
6 quarters
|
|
|
FONR
3407
DELISTED
Fonar
FONR
| $1.59M | ﹤0.01% |
59,742
+12,808
| +27% | +$357K |
2017 Q4
2 quarters
|
|
|
ATRI
3408
DELISTED
Atrion Corp
ATRI
| $1.59M | ﹤0.01% |
2,645
-1,203
| -31% | -$723K |
2016 Q3
7 quarters
|
|
3409
ProShares MSCI Emerging Markets Dividend Growers ETF
EMDV
$7.11M
| $1.58M | ﹤0.01% |
28,627
+1,539
| +6% | +$89.8K |
2017 Q4
2 quarters
|
|
3410
American Coastal Insurance
ACIC
$437M
| $1.58M | ﹤0.01% |
80,884
+30,847
| +62% | +$611K |
2017 Q2
4 quarters
|
|
|
MODN
3411
DELISTED
MODEL N, INC.
MODN
| $1.58M | ﹤0.01% |
85,077
-11,456
| -12% | -$202K |
2016 Q4
6 quarters
|
|
3412
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.14B
| $1.58M | ﹤0.01% |
32,131
-2,309
| -7% | -$113K |
2015 Q1
13 quarters
|
|
|
BCOV
3413
DELISTED
Brightcove, Inc.
BCOV
| $1.58M | ﹤0.01% |
163,299
+156,375
| +2,258% | +$1.44M |
2016 Q4
6 quarters
|
|
|
CS
3414
DELISTED
Credit Suisse Group
CS
| $1.58M | ﹤0.01% |
105,898
-128,776
| -55% | -$2.08M |
2013 Q2
20 quarters
|
|
3415
CALL
Corcept Therapeutics
CORT
$12.3B
| $1.57M | ﹤0.01% |
+100,000
| New | +$1.74M |
2018 Q2
0 quarters
|
|
3416
Digi International
DGII
$2.79B
| $1.57M | ﹤0.01% |
119,069
-51,274
| -30% | -$612K |
2015 Q1
13 quarters
|
|
3417
American Vanguard Corp
AVD
$51.6M
| $1.56M | ﹤0.01% |
68,071
-142,601
| -68% | -$3.15M |
2013 Q2
20 quarters
|
|
|
AMWD
3418
DELISTED
American Woodmark
AMWD
| $1.56M | ﹤0.01% |
17,063
-47,887
| -74% | -$4.42M |
2013 Q3
19 quarters
|
|
3419
Amplify Energy
AMPY
$182M
| $1.56M | ﹤0.01% |
114,584
-9,182
| -7% | -$124K |
2017 Q2
4 quarters
|
|
3420
FreightCar America
RAIL
$215M
| $1.56M | ﹤0.01% |
92,773
-16,648
| -15% | -$256K |
2015 Q4
10 quarters
|
|
3421
Seneca Foods Class A
SENEA
$1.2B
| $1.56M | ﹤0.01% |
57,696
+12,352
| +27% | +$346K |
2013 Q2
20 quarters
|
|
3422
CALL
Heron Therapeutics
HRTX
$67.6M
| $1.55M | ﹤0.01% |
+40,000
| New | +$1.27M |
2018 Q2
0 quarters
|
|
3423
Compass Minerals
CMP
$916M
| $1.55M | ﹤0.01% |
23,614
+1,613
| +7% | +$107K |
2015 Q4
10 quarters
|
|
3424
OrthoPediatrics
KIDS
$566M
| $1.55M | ﹤0.01% |
58,294
-32,392
| -36% | -$691K |
2017 Q4
2 quarters
|
|
3425
Modine Manufacturing
MOD
$10B
| $1.55M | ﹤0.01% |
85,094
-34,997
| -29% | -$657K |
2016 Q4
6 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2018 Portfolio in Review
As of Q2 2018, JP Morgan Chase held 5,918 positions worth $486B, up 4.2% from $467B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2018 filing shows 539 new, 2,430 increased, 2,080 reduced and 346 closed positions. Its largest new stake was Evergy: 3,598,208 shares worth $202M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2018 buy was Evergy: 3,598,208 shares worth $202M.
- JP Morgan Chase added most to Salesforce in Q2 2018, an estimated $1.09B increase.
- JP Morgan Chase's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.58B.
- JP Morgan Chase fully exited Time Warner Inc in Q2 2018, selling an estimated $764M.
- JP Morgan Chase's ten largest holdings make up 17% of its $486B portfolio in Q2 2018.
- JP Morgan Chase opened 539 new positions and closed 346 in Q2 2018.
- JP Morgan Chase's portfolio value rose 4.2% quarter-over-quarter to $486B.
Based on JP Morgan Chase's 13F filing for Q2 2018, filed 14 Aug 2018.